BimalBhindiMDMSc, FRCSC

PubMed

• 11 citations
  Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy.
  Nityam Rathi, Yosuke Yasuda, Diego Aguilar Palacios, Worapat Attawettayanon, Jianbo Li
  European Urology Open Science. 2022-06-01
• 4 citations
  Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma.
  Jack R Andrews, Christine M Lohse, Stephen A Boorjian, Bradley C Leibovich, Houston Thompson
  Urologic Oncology. 2022-04-01
• 7 citations
  Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers.
  Alice Dragomir, Sara Nazha, Simon Tanguay, Rodney H. Breau, Bimal Bhindi
  European Urology Focus. 2021-11-01

Journal Articles

• Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy  
  Bhindi B, Xie WY, Kulkarni GS, Hamilton RJ, Nesbitt M, Finelli A, Zlotta AR, Evans A, van der Kwast TH, Alibhai SM, Trachtenberg J, Fleshner NE, Urology, 1/1/2016
• Author Reply re: Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy  
  Bhindi B, Fleshner NE, Urology, 1/1/2016
• Prostate cancer risk prediction using the novel versions of the ERSPC and PCPT risk calculators: Independent validation and comparison in a contemporary European cohort  
  Poyet C, Nieboer D, Bhindi B, Kulkarni GS, Wiederkehr C, Wettstein MS, Largo R, Wild P, Sulser T, Hermanns T, BJU Int, 1/1/2016
• Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy  
  Bhindi B, Hermanns T, Wei Y, Yu J, Richard PO, Wettstein MS, Templeton A, Li K, Sridhar SS, Jewett MA, Fleshner NE, Zlotta AR, Kulkarni GS, Br J Cancer, 1/1/2016
• The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis  
  Nayan M, Bhindi B, Yu JL, Mamdani M, Fleshner NE, Hermanns T, Chung P, Milosevic M, Bristow R, Warde P, Hamilton RJ, Finelli A, Jewett MAS, Zlotta AR, Sridhar SS, Kulk..., Can Urol Assoc J, 1/1/2016
• External evaluation of a novel prostate cancer risk calculator (ProstateCheck) based on data of the Swiss arm of the ERSPC  
  Poyet C, Wettstein MS, Lundon DJ, Bhindi B, Kulkarni GS, Saba K, Sulser T, Vickers AJ, Hermanns T, J Urol, 1/1/2016
• The impact of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder  
  Nayan M, Bhindi B, Yu JL, Hermanns T, Mohammed A, Hamilton RJ, Finelli A, Jewett MAS, Zlotta AR, Fleshner NE, Kulkarni GS, Uro Oncol, 1/1/2015
• Impact of the US Preventive Services Task Force recommendations against PSA screening on prostate biopsy and cancer detection rates  
  Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamilton RJ, Trachtenberg J, Zlotta AR, Evans A, van der Kwast TH, Toi A, Fleshner NE, J Urol, 1/1/2015
• Electrochemical Red-Ox Therapy of Prostate Cancer in Nude Mice  
  Cury FL, Bhindi B, Rocha J, Scarlata E, El Jurdi K, Ladouceur M, Beauregard S, Vijh AK, Taguchi Y, Chevalier S, Bioelectrochemistry, 1/1/2015
• Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort  
  Bhindi B, Locke J, Alibhai SMH, Kulkarni GS, Margel DS, Hamilton RJ, Finelli A, Trachtenberg J, Zlotta AR, Toi A, Hersey KM, Evans A, van der Kwast TH, Fleshner NE, Eur Urol., 1/1/2015
• Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder  
  Hermanns T, Bhindi B, Wei Y, Yu J, Noon A, Richard P, Bhatt J, Almatar A, Jewett MAS, Fleshner NE, Zlotta AR, Templeton A, Kulkarni GS, Br J Cancer, 1/29/2014
• Metabolic Syndrome as a Marker for Prostate Cancer: Still a Work in Progress  
  Bhindi B, Fleshner NE. Reply from Authors re: Andrea Gallina, Alessandro Nini, Francesco Montorsi, Alberto Briganti, Eur Urol., 1/13/2014
• The impact of aspirin and other nonsteroidal anti-inflammatory drug use on the risk of prostate cancer detection on biopsy  
  Bhindi B, Margel D, Hamilton RJ, Fernandes KA, Trottier G, Hersey KM, Finelli A, Trachtenberg J, Zlotta AR, Kulkarni GS, Toi A, Evans A, van der Kwast TH, Fleshner NE, Urology, 1/1/2014
• Metabolic syndrome and diabetes for the urologist  
  Fleshner NE, Bhindi B, Can Urol Assoc J, 1/1/2014
• Obesity is associated with risk of progression for low risk prostate cancers being managed expectantly  
  Bhindi B, Kulkarni GS, Finelli A, Alibhai SMH, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey KM, Jewett MAS, Zlotta AR, Trachtenberg J, Fleshner NE, Eur Urol, 1/1/2014
• The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy  
  Bhindi B, Yu J, Kuk C, Sridhar SS, Hamilton RJ, Finelli A, Jewett MAS, Evans A, Fleshner NE, Zlotta AR, Kulkarni GS, J Urol, 1/1/2014
• Obesity is associated with larger prostate volume but not with worse urinary symptoms: Analysis of a large multi-ethnic cohort  
  Bhindi B, Margel D, Trottier G, Hamilton RJ, Kulkarni GS, Hersey KM, Finelli A, Trachtenberg J, Zlotta AR, Toi A, Evans A, van der Kwast TH and Fleshner NE, Urology, 1/1/2014
• Reply: The impact of aspirin and other non-steroidal anti-inflammatory drug use on the risk of prostate cancer detection on biopsy  
  Bhindi B, Urology, 1/1/2014
• Obesity and benign prostatic hyperplasia: Analysis of a large cohort undergoing transrectal ultrasound guided prostate biopsy  
  Bhindi B, Trottier G, Elharram M, Fernandes KA, Lockwood G, Hersey KM, Toi A, Finelli A, Evans A, van der Kwast TH, and Fleshner NE, BJU Int, 1/1/2012
• Join now to see all

Abstracts/Posters

• Is prostate cancer a marker for metabolic syndrome or good health? Analysis of a propensity-score matched population-based cohort.
  Bhindi B, Fleshner NE, Kulkarni GS, Sutradhar R, Lipscombe LL, Jembere N, Saskin R, Alibhai SMH, Canadian Urological Association 2013 Annual Meeting, Niagara Falls, ON, 1/30/2015
• Determining the best complete blood count-based biomarker for oncologic outcomes following radical cystectomy for urothelial carcinoma of the bladder. Moderated poster...
  Bhindi B, Hermanns T, Wei Y, Yu J, Templeton A, Noon AP, Bhatt JR, Richard PO, Almatar A, Jewett MAS, Hamilton RJ, Finelli A, Fleshner NE, Zlotta AR, and Kulkarni GS, Canadian Urological Association 2013 Annual Meeting, Niagara Falls, ON, 1/30/2015
• Prognostic utility of the neutrophil-tolymphocyte ratio in a large cohort of 2,407 men undergoing radical prostatectomy for clinically localized prostate cancer.
  Bhindi B, Hermanns T, Wei Y, Templeton A, Richard PO, Bhatt JR, Noon AP, Jewett MAS, Hamilton RJ, Trachtenberg, J, Finelli A, Fleshner NE, Zlotta AR, Kulkarni GS, Canadian Urological Association Annual Meeting, Niagara Falls, ON, 1/30/2015
• Creation of the Toronto Biopsy Avoidance Tools (T-BAT) with clinical parameter-only and adipokine biomarker-augmented versions
  Bhindi B, Mohammed A, Jiang H, Hamilton RJ, Toi A, Finelli A, Trachtenberg J, Zlotta AR, van der Kwast TH, Evans A, Fleshner NE, Kulkarni GS, European Association of Urology Annual Meeting, Madrid, Spain, 1/23/2015
• Creation of the Toronto Biopsy Avoidance Tools (T-BAT) with clinical parameter-only and adipokine biomarker-augmented versions.
  Bhindi B, Mohammed A, Jiang H, Hamilton RJ, Toi A, Finelli A, Trachtenberg J, Zlotta AR, van der Kwast TH, Evans A, Fleshner NE, Kulkarni GS., European Association of Urology Annual Meeting, Madrid, Spain, 1/21/2015
• Creation of the Toronto Biopsy Avoidance Tools (T-BAT) with clinical parameter-only and adipokine biomarker-augmented versions
  Bhindi B, Mohammed A, Jiang H, Hamilton RJ, Toi A, Finelli A, Trachtenberg J, Zlotta AR, van der Kwast TH, Evans A, Fleshner NE, Kulkarni GS, American Urological Association Annual Meeting, New Orleans, LA, 1/19/2015
• Determining the best complete blood count-based biomarker for oncologic outcomes following radical cystectomy for urothelial carcinoma of the bladder. Moderated poster...
  Bhindi B, Hermanns T, Wei Y, Yu J, Templeton A, Noon AP, Bhatt JR, Richard PO, Almatar A, Jewett MAS, Hamilton RJ, Finelli A, Fleshner NE, Zlotta AR, and Kulkarni GS, American Urological Association Annual Meeting, New Orleans, LA, 1/18/2015
• Impact of metabolic syndrome on stage, grade and overall failure in men undergoing radical prostatectomy for prostate cancer
  Bhindi B, Xie WY, Hamilton RJ, Kulkarni GS, Kalnin R, Nesbitt M, Alibhai SMH, Finelli A, Zlotta AR, Trachtenberg J, Fleshner NE, American Urological Association Annual Meeting, New Orleans, LA, 1/18/2015
• Influence of metabolic syndrome on prostate cancer stage, grade and overall recurrence in men undergoing radical prostatectomy
  Bhindi B, Xie WY, Kulkarni GS, Hamilton RJ, Kalnin R, Nesbitt M, Alibhai SMH, Finelli A, Zlotta AR, Evans A, van der Kwast TH, Trachtenberg T, Fleshner NE, Annual Charles J. Robson Research Day, Toronto, ON, Canada, 1/9/2015
• Determining the best complete blood count-based biomarker for oncologic outcomes following radical cystectomy for urothelial carcinoma of the bladder.
  Bhindi B, Hermanns T, Wei Y, Yu J, Templeton A, Noon AP, Bhatt JR, Richard PO, Almatar A, Jewett MAS, Hamilton RJ, Finelli A, Fleshner NE, Zlotta AR, and Kulkarni GS., Annual Charles J. Robson Research Day, Toronto, ON, Canada, 1/9/2015
• Minimizing the use of repeat prostate biopsy in men with a prior negative prostate biopsy: Creation of a predictive biopsy-avoidance tool to guide clinicians
  Bhindi B, Mohammed A, Jiang H, Hamilton RJ, Toi A, Finelli A, Trachtenberg J, Zlotta AR, van der Kwast TH, Evans A, Fleshner NE, Kulkarni GS, Annual Charles J. Robson Research Day, Toronto, ON, Canada, 1/9/2015
• Inflammation, Prostate Cancer and Prostate Cancer Grade in Unscreened Asian and Caucasian men: An autopsy study
  Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, Takahashi H, Kuk C, Kovylina M, Bhindi B, Aldaoud N, Fleshner NE, Finelli A, Klotz L, Lockwood G, Sykes J, ..., Annual Charles J. Robson Research Day, Toronto, ON, Canada, 1/9/2015
• Prostate Cancer Is Not Associated with Lower Urinary Tract Symptoms in the Modern Era: Analysis of a Contemporary Propensity Score-Matched Cohort.
  Bhindi B, Kulkarni GS, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Jewett MAS, Zlotta AR, Trachtenberg J, Finelli A, Fleshner NE, Canadian Urological Association Annual Meeting, St. John's, NL, Canada, 1/30/2014
• Obesity Is Associated with an Increased Risk of Progression for Men on Active Surveillance for Low Risk Prostate Cancer
  Bhindi B, Kulkarni GS, Finelli A, Alibhai SMH, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey KM, Jewett MAS, Zlotta AR, Trachtenberg J, Fleshner NE., Canadian Urological Association Annual Meeting, St. John's, NL, Canada, 1/30/2014
• Metabolic Syndrome and Oncologic Outcomes in Men Undergoing Radical Prostatectomy for Prostate Cancer.
  Bhindi B, Xie WY, Hamilton RJ, Kulkarni GS, Kalnin R, Nesbitt M, Alibhai SMH, Finelli A, Zlotta AR, Trachtenberg J, Fleshner NE., Canadian Urological Association Annual Meeting, St. John's, NL, Canada, 1/30/2014
• Prostate biopsy trends in relation to U.S. Preventive Services Task for recommendations against routine PSA-based screening: A time-series analysis
  Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamilton RJ, Trachtenberg J, Zlotta AR, Toi A, Evans A, van der Kwast TH, Fleshner NE., American Urological Association Annual Meeting, Orlando, FL, 1/19/2014
• Prostate biopsy trends in relation to U.S. Preventative Task for recommendations against routine PSA-based screening: A time-series analysis.
  Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamilton RJ, Trachtenberg J, Zlotta AR, Toi A, Evans A, van der Kwast TH, Fleshner NE., European Association of Urology 2014 Annual Congress, Stockholm, Sweden, 1/14/2014
• The association between metabolic syndrome and benign prostatic enlargement depends on prostate cancer status
  Bhindi B, Kulkarni GS, Alibhai SMH, Hamilton RJ, Toi A, Trachtenberg J, Zlotta AR, Finelli A, Fleshner NE, 34th Congress of the Societe Internationale d'Urologie, Glasgow, Scotland, 1/13/2014
• Prostate biopsy trends in relation to U.S. Preventive Services Task for recommendations against routine PSA-based screening: A time-series analysis.
  Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamilton RJ, Trachtenberg J, Zlotta AR, Toi A, Evans A, van der Kwast TH, Fleshner NE, 34th Congress of the Societe Internationale d'Urologie, Glasgow, Scotland, 1/13/2014
• Prostate Cancer Is Not Associated with Lower Urinary Tract Symptoms in the Modern Era: Analysis of a Contemporary Propensity Score-Matched Cohort
  Bhindi B, Kulkarni GS, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Jewett MAS, Zlotta AR, Trachtenberg J, Finelli A, Fleshner NE., 34th Congress of the Societe Internationale d'Urologie, Glasgow, Scotland, 1/13/2014
• Metabolic Syndrome and Oncologic Outcomes in Men Undergoing Radical Prostatectomy for Prostate Cancer.
  Bhindi B, Xie WY, Hamilton RJ, Kulkarni GS, Kalnin R, Nesbitt M, Alibhai SMH, Finelli A, Zlotta AR, Trachtenberg J, Fleshner NE, 34th Congress of the Societe Internationale d'Urologie, Glasgow, Scotland, 1/13/2014
• Impact of the U.S. Preventive Task Force recommendations against PSA based screening on prostate biopsy and cancer detection rates
  Bhindi B, Mamdani M, Kulkarni GS, Finelli A, Hamilton RJ, Trachtenberg J, Zlotta AR, Evans A, van der Kwast TH, Toi A, Fleshner NE, Annual Charles J. Robson Research Day, Toronto, ON, Canada, 1/10/2014
• Reducing over-diagnosis of prostate cancer with the judicious use of first-time biopsy: Validation of the Toronto Biopsy Avoidance Tool (T-BAT)
  Bhindi B, Jiang H, Hamilton RJ, Toi A, Finelli A, Trachtenberg J, Zlotta AR, van der Kwast TH, Evans A, Fleshner NE, Kulkarni GS, Annual Charles J. Robson Research Day, Toronto, ON, Canada, 1/10/2014
• Obesity is associated with risk of progression for low risk prostate cancer being managed expectantly
  Bhindi B, Kulkarni GS, Finelli A, Alibhai SMH, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey KM, Jewett MAS, Zlotta AR, Trachtenberg J, Fleshner NE, University of Toronto Department of Surgery Gallie Research Day, 1/9/2014
• Obesity is associated with risk of progression for low risk prostate cancer being managed expectantly.
  Bhindi B, Kulkarni GS, Finelli A, Alibhai SMH, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey KM, Jewett MAS, Zlotta AR, Trachtenberg J, Fleshner NE, Institute of Health Policy, Management & Evaluation Annual Research Day, 1/7/2014
• Join now to see all